188 related articles for article (PubMed ID: 38440666)
21. [The Impact of Subtotal Petrosectomy in Cochlea Implantation].
Issing PR; Atanasova-Koch S; Schneider J; Issing C
Laryngorhinootologie; 2021 Nov; ():. PubMed ID: 34798673
[TBL] [Abstract][Full Text] [Related]
22. Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery.
Linder T; Schlegel C; DeMin N; van der Westhuizen S
Otol Neurotol; 2009 Jan; 30(1):41-7. PubMed ID: 18849883
[TBL] [Abstract][Full Text] [Related]
23. Surgical outcomes of simultaneous cochlear implantation with subtotal petrosectomy.
Lee S; Lee JB; Chung JH; Park KW; Choi JW
Auris Nasus Larynx; 2020 Dec; 47(6):943-949. PubMed ID: 32518029
[TBL] [Abstract][Full Text] [Related]
24. Cochlear implantation in patients with chronic otitis: indications for subtotal petrosectomy and obliteration of the middle ear.
Issing PR; Schönermark MP; Winkelmann S; Kempf HG; Ernst A
Skull Base Surg; 1998; 8(3):127-31. PubMed ID: 17171047
[TBL] [Abstract][Full Text] [Related]
25. Temporal bone meningoencephaloceles and cerebrospinal fluid leaks: experience in a tertiary care hospital.
Gupta A; Sikka K; Irugu DVK; Verma H; Bhalla AS; Thakar A
J Laryngol Otol; 2019 Mar; 133(3):192-200. PubMed ID: 30777139
[TBL] [Abstract][Full Text] [Related]
26. Subtotal petrosectomy and Codacs™: new possibilities in ears with chronic infection.
Schwab B; Kludt E; Maier H; Lenarz T; Teschner M
Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1387-91. PubMed ID: 26092235
[TBL] [Abstract][Full Text] [Related]
27. Subtotal Petrosectomy (SP) in Cochlear Implantation (CI): A Report of 92 Cases.
Arístegui I; Aranguez G; Casqueiro JC; Gutiérrez-Triguero M; Pozo AD; Arístegui M
Audiol Res; 2022 Feb; 12(2):113-125. PubMed ID: 35314609
[TBL] [Abstract][Full Text] [Related]
28. Acquired cholesteatoma after cochlear implants: case series and literature review.
Sykopetrites V; Di Maro F; Sica E; Cristofari E
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1285-1291. PubMed ID: 37776344
[TBL] [Abstract][Full Text] [Related]
29. The use of subtotal petrosectomy in cochlear implant candidates with chronic otitis media.
Szymański M; Ataide A; Linder T
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):363-70. PubMed ID: 25708413
[TBL] [Abstract][Full Text] [Related]
30. [Indications for middle ear obliteration within the scope of cochlear implant management].
Issing PR; Schönermark M; Kempf HG; Lenarz T
Laryngorhinootologie; 1996 Dec; 75(12):727-31. PubMed ID: 9081277
[TBL] [Abstract][Full Text] [Related]
31. Lateral skull base surgery in a pediatric population: A 25-year experience in a referral skull base center.
Grinblat G; Prasad SC; Fulcheri A; Laus M; Russo A; Sanna M
Int J Pediatr Otorhinolaryngol; 2017 Mar; 94():70-75. PubMed ID: 28167016
[TBL] [Abstract][Full Text] [Related]
32. Renewed Concept of Mastoid Cavity Obliteration with the Use of Temporoparietal Fascial Flap Injected by Injectable Platelet-Rich Fibrin after Subtotal Petrosectomy for Cochlear Implant Patients.
Zwierz A; Masna K; Burduk P; Hackenberg S; Scheich M
Audiol Res; 2024 Mar; 14(2):280-292. PubMed ID: 38525686
[No Abstract] [Full Text] [Related]
33. Management of chronic otitis media by subtotal petrosectomy.
Altuna X; Navarro JJ; Goiburu M; Palicio I
Acta Otorrinolaringol Esp; 2016; 67(5):249-53. PubMed ID: 26753917
[TBL] [Abstract][Full Text] [Related]
34. [Lateral petrosectomy in pathology of the temporal bone].
Bartoszewicz R; Niemczyk K; Morawski K; Bruzgielewicz A; Sokołowski J
Otolaryngol Pol; 2010 Jun; 64(7):81-6. PubMed ID: 21171318
[TBL] [Abstract][Full Text] [Related]
35. Impact of Chronic Suppurative Otitis Media in Pediatric Cochlear Implant Recipients-Insight into the Challenges from a Tertiary Referral Center in UK.
Baruah P; Hanvey K; Irving R; Tzifa K
Otol Neurotol; 2017 Jun; 38(5):672-677. PubMed ID: 28333779
[TBL] [Abstract][Full Text] [Related]
36. Subtotal petrosectomy and mastoid obliteration in adult and pediatric cochlear implant recipients.
Barañano CF; Kopelovich JC; Dunn CC; Gantz BJ; Hansen MR
Otol Neurotol; 2013 Dec; 34(9):1656-9. PubMed ID: 24136310
[TBL] [Abstract][Full Text] [Related]
37. Indications and outcome of subtotal petrosectomy for active middle ear implants.
Verhaert N; Mojallal H; Schwab B
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1243-8. PubMed ID: 22829158
[TBL] [Abstract][Full Text] [Related]
38. Prevention and management of vascular complications in middle ear and cochlear implant surgery.
Di Lella F; Falcioni M; Piccinini S; Iaccarino I; Bacciu A; Pasanisi E; Cerasti D; Vincenti V
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3883-3892. PubMed ID: 28932983
[TBL] [Abstract][Full Text] [Related]
39. Measuring growth of residual cholesteatoma in subtotal petrosectomy.
Hellingman CA; Logher JLE; Kammeijer Q; Waterval JJ; Ebbens FA; van Spronsen E
Acta Otolaryngol; 2019 May; 139(5):415-420. PubMed ID: 30890007
[TBL] [Abstract][Full Text] [Related]
40. Active middle ear implants in patients undergoing subtotal petrosectomy: long-term follow-up.
Henseler MA; Polanski JF; Schlegel C; Linder T
Otol Neurotol; 2014 Mar; 35(3):437-41. PubMed ID: 24492140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
